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STUDY PROTOCOL Open Access
A complex behavioural change intervention
to reduce the risk of diabetes and
prediabetes in the pre-conception period in
Malaysia: study protocol for a randomised
controlled trial
Jutta K. H. Skau1*, Awatef Binti Amer Nordin2, Julius C. H. Cheah3, Roslinah Ali2, Ramli Zainal4, Tahir Aris5,
Zainudin Mohd Ali6, Priya Matzen7, Regien Biesma8,7, Jens Aagaard-Hansen9,1, Mark A. Hanson7
and Shane A. Norris1
Abstract
Background: Over the past two decades, the population of Malaysia has grown rapidly and the prevalence of
diabetes mellitus in Malaysia has dramatically increased, along with the frequency of obesity, hyperlipidaemia and
hypertension. Early-life influences play an important role in the development of non-communicable diseases.
Indeed, maternal lifestyle and conditions such as gestational diabetes mellitus or obesity can affect the risk of
diabetes in the next generation. Lifestyle changes can help to prevent the development of type 2 diabetes mellitus.
This is a protocol for an unblinded, community-based, randomised controlled trial in two arms to evaluate the
efficacy of a complex behavioural change intervention, combining motivational interviewing provided by a
community health promoter and access to a habit formation mobile application, among young Malaysian women
and their spouses prior to pregnancy.
Method/design: Eligible subjects will be Malaysian women in the age group 20 to 39 years, who are nulliparous,
not diagnosed with diabetes and own a smartphone. With an alpha-value of 0.05, a statistical power of 90 %, 264
subjects will need to complete the study. Subjects with their spouses will be randomised to either the intervention
or the control arm for an 8-month period. The primary endpoint is change in waist circumference from baseline to
end of intervention period and secondary endpoints are changes in anthropometric parameters, biochemical
parameters, change in health literacy level, dietary habits, physical activity and stress level. Primary endpoint and the
continuous secondary endpoints will be analysed in a linear regression model, whereas secondary endpoints on an
ordinal scale will be analysed by using the chi-squared test. A multivariate linear model for the primary endpoint
will be undertaken to account for potential confounders. This study has been approved by the Medical Research
and Ethics Committee of the Ministry of Health Malaysia (protocol number: NMRR-14-904-21963) on 21 September 2015.
(Continued on next page)
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Discussion: This study protocol describes the first community-based randomised controlled trial, to examine the efficacy
of a complex intervention in improving the pre-pregnancy health of young Malaysian women and their spouses. Results
from this trial will contribute to improve policy and practices regarding complex behavioural change interventions to
prevent diabetes in the pre-conception period in Malaysia and other low- and middle-income country settings.
Trial registration: This trial is registered with ClinicalTrials.gov (www.clinicaltrials.gov) on 30 November 2015, Identifier:
NCT02617693.
Keywords: Pre-conception, Pre-pregnancy, Complex behavioural change intervention, E-health, Malaysia, Lifestyle
intervention, Motivational counselling
Background
Diabetes mellitus (DM) is one of the most common
non-communicable diseases (NCDs) across the world.
Today 387 million people are living with diabetes
whereas 46.3 % remain undiagnosed. The prevalence of
DM is expected to increase to 53 % by 2035 [1]. DM is
an important public health concern in Malaysia. Over
the past two decades, the population of Malaysia has
grown rapidly and the prevalence of DM in Malaysia has
increased dramatically, along with the prevalence of
obesity, hyperlipidaemia and hypertension. The National
Health and Morbidity Survey (NHMS) 2015 estimated
the prevalence of DM in adults 18 years old and over
was 11.6 % in 2006 and 17.5 % in 2015 [2]. The prevalence
of DM has almost tripled over the past two decades in the
younger generations (20–39 years old) [2, 3].
There is a body of evidence showing that lifestyle
changes, such as achieving a healthy body weight, can
help to prevent the development of type 2 diabetes mellitus
(T2DM) [4–6]. Complex behavioural change interventions,
or lifestyle intervention trials, have also moved in the past
decade from targeting high-risk to low-risk populations
and interventions have also been targeted earlier in the life
course [7–9]. The use of new communication technologies,
such as computer-based interventions, and empowerment
techniques such as goal setting, have been found to be
helpful and eventually more effective than other inter-
ventions on weight loss and self-management of T2DM
[10–13]. Lifestyle interventions seek to delay or halt the
development of T2DM and achieve, e.g. a healthy body
weight. Goal setting requires a coordinated team effort that
involves the person at risk in the decision-making process.
Evidence demonstrates that structured, intensive lifestyle
programmes involving participant education, individualised
counselling, reduced dietary energy and fat intake, regular
physical activity, and frequent participant contact are ne-
cessary to produce long-term weight loss of 5–7 % [14].
The Developmental Origins of Health and Disease
(DOHaD) concept describes how during early life (at con-
ception, and/or during foetal life, infancy and early child-
hood), the environment induces changes in development
that have a long-term impact on later health and disease
risk [15]. Early-life influences play an important role in the
development of NCDs, and maternal lifestyle and condi-
tions such as gestational diabetes mellitus (GDM) or obes-
ity can affect the risk of diabetes in the next generation
[16, 17]. Besides complications of pregnancy such as
GDM, hypertension, and preeclampsia that directly affect
the pregnancy outcome, the mother’s health during preg-
nancy affects her child’s risk of becoming overweight or
obese. If the mother makes lifestyle choices that lead to
unbalanced nutrition, obesity, stress, smoking and others,
her child is more vulnerable to diabetes and other NCDs
[18]. Children born to mothers with GDM have a four to
eight times higher risk of obesity, glucose intolerance and
T2DM in adolescence or young adulthood [19].
The Jom Mama project has been designed to develop
an intervention which responds to this rising public
health challenge, focusing on young Malaysian women
and their spouses. The overall aim of the Jom Mama
project is to demonstrate whether a complex behavioural
change intervention will change markers of health in the
young Malaysian woman in the pre-conception period,
before evaluating whether the intervention affects the
pregnancy course and the neonate susceptibility to obesity
and diabetes. The Jom Mama project is a public-private
partnership between the Ministry of Health (MoH),
Malaysia; the University of Southampton, UK; the Univer-
sity of Witwatersrand, South Africa; the Steno Diabetes
Centre, Denmark; and Novo Nordisk, Denmark. The pro-
ject was initiated in 2012 and is following Intervention
Mapping guidelines, which is a systematic framework to
develop health promotion programmes [20]. The Jom
Mama project is conducted in three phases; phase 1: to
develop knowledge on the lifestyle of young couples in
Malaysia and identify the barriers and facilitators of health
[18, 21]; phase 2: to develop intervention matrices and de-
velop an intervention package based on the outcome from
phase 1; and phase 3: to implement and evaluate the de-
veloped intervention package in a randomised control trial
(RCT). In this paper we will present the study protocol for
an unblinded, community-based, RCT with two arms to
evaluate the complex behavioural change intervention
developed in phase 2 of the Jom Mama project.
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Methods/design
Aim
The primary objective of the trial is to evaluate the efficacy
of a complex behavioural change intervention combining
behaviour change counselling provided by community
health promoters (CHPs) and utilisation of an E-health
platform to enhance women’s health prior to pregnancy.
This will be measured through the change in waist circum-
ference after the 8-month intervention period between fe-
male subjects exposed to the intervention and female
subjects exposed to standard of care in a control group.
The secondary objectives are to evaluate the efficacy of the
intervention on health literacy, dietary habits, physical ac-
tivity, sedentary behaviour and stress level.
Study design
The trial is designed as an unblinded, RCT to assess the
efficacy of a complex behavioural change intervention
aiming to improve the overall health of young women
prior to their first pregnancy. The intervention follow-up
period is 8 months from randomisation/baseline. After end
trial the subjects will be monitored for a period of
12 months for pregnancy. Figure 1 gives the flow diagram
of the trial. The trial was designed following the Standard
Protocol Items: Recommendations for Interventional Trials
(SPIRIT) 2013 statement (see Additional file 1).
Site and participation selection
The trial will be carried out in the district of Seremban
in the state of Negeri Sembilan, Malaysia. This location
was selected due to Negeri Sembilan having a higher
prevalence of diabetes (22.0 %) compared to the national
prevalence (15.2 %) [22]. Ethnic diversity is one of the
key features of Malaysia and the district of Seremban has
a representation of the three major ethnic groups: Malay,
Chinese and Indian, 67.4, 24.6 and 7.3 %, respectively [23].
The target subjects will be newly registered married or
engaged women. The woman will be recruited with her
spouse, who also will be exposed to the intervention.
Inclusion and exclusion criteria
Eligible subjects must meet all the following inclusion
criteria:
1. Female and between the ages of 20–39 years
2. Nulliparous
3. Not pregnant at the time of signing the informed
consent
4. Own a smartphone, with either an Android operating
system version 4.1 and above or iOS operating system
7.0 and above, and have Internet access
Subjects meeting any of the following criteria will be
excluded from participation in the trial:
1. Female subject undergoing treatment for type 1 or 2
diabetes mellitus
2. Subject not residing in the district of Seremban
Screening
Newly married or engaged women and their spouses will
be recruited from 2 November 2015, primarily from five
designated primary health clinics in the district of
Seremban, whereas Muslim Malay couples are obligated to
conduct a pre-marriage screening, which involves a HIV/
AIDS test. Other sites in Seremban such as the state mar-
riage registration office, temples and churches or other sites
(work places, malls, gyms, etc.) will also be approached for
recruitment purposes. A research officer will meet the
young couples face-to-face and provide an explanation of
the study rationale and a description of the Jom Mama pro-
ject. The women and spouse will be given an opportunity
to ask questions and those who are interested in the study
will have their contact details recorded for further contact
and arrangements for a baseline visit. If possible, the couple
will be given a clinic appointment for baseline measure-
ments at one of the five designated primary health clinics in
Seremban. If the couple need time to consider their in-
volvement, the research officer will follow-up with three
phone calls over the next 3 weeks. If, at these phone calls
the couple accepts participation in the trial, a baseline ap-
pointment will be made. If the couple does not answer the
three phone calls or rejects the offer to participate, they will
be dropped from the participation registration list.
Intervention
The intervention has two components. The first compo-
nent is an interaction with a CHP who will be in contact
with the women and their spouses during the 8-month
intervention period. These contacts will be a combin-
ation of three face-to-face meetings, three phone calls
and communication through Whatsapp group chat. The
CHP will use motivational counselling techniques, i.e.
motivational interviewing, to support and motivate the
young women and their spouses to live a healthier
lifestyle. The second component is an E-health platform
which consists of two elements: (1) a mobile application
in the form of a habit formation application, where sub-
jects and spouses can select different challenges for
obtaining a healthy diet, more physical activity and less
sedentary behaviour during the intervention period; and
(2) a web-based back-end interface which can be accessed
by the CHP, which will be her tool to assess the women
and their spouses’ lifestyle situation. The CHP uses a
dashboard to follow the progress of subject and spouse in
performing the challenges, and uses the information to
interact with the subject and her spouse during the con-
tact points in the intervention. Figure 2 presents screen
shots of the web-based application the CHPs are using.
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The CHP will function as a personal coach to engage, sup-
port and guide the young woman and her spouse toward
achieving and maintaining a healthier lifestyle. During the
interaction over the intervention period of 8 months, the
CHPs will assess the subject and her spouse’s health risks
and behaviour, share information on healthy living and
support the subjects and spouses to reach their personal
health goals. The objectives of each contact point are
presented in Table 1.
The CHP role will be carried out by community nurses
who are currently working in primary health care in
Malaysia. Prior to the start of the intervention, the
Fig. 1 The flow diagram of the Jom Mama trial
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community nurses undertook training in becoming a
CHP. This was a 5-day training programme with ses-
sions in motivational interviewing techniques, the use of
the E-health platform and basic knowledge of healthy
diet and physical activity. The training was carried out
by local trainers who are social-psychologists with
Fig. 2 Screen shot from the web application, showing the couples’ dashboard. Screen shot a Shows the overview of all couples under one
community health promoter (CHP). The traffic lights give an indication on how active the couple are in performing their selected challenges.
The second column indicates when the couple was last active on the mobile application. The last column informs when the CHP has the next
appointment with the couple. Screen shot b Shows the progress over time for one couple. The graphic can shift between wife and husband and,
in this example, it is only showing the wife. The upper columns indicate how many times the challenges have been performed per month. The lower
columns indicate how many times each challenge has been performed
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expertise in motivational interviewing techniques, pro-
fessional dieticians and physical activity experts. During
the trial, refreshment training with the social-psychologist
trainers will take place to support and help the CHPs in
addressing challenging situations they encountered with
the young women and their spouses.
The mobile application is a habit-formation applica-
tion, which incorporates personal goal setting, progress
tracking and general information on healthy lifestyles.
The mobile application has two key components com-
prising diet and physical activity. Under each domain
several challenges have been developed which can be
selected by the subject on a monthly basis in dialogue
with the CHP. The application will suggest several chal-
lenges for healthy eating, such as making healthy food
choices and healthy food preparation, and interactive
options for the subject to stay active and prevent seden-
tary behaviour. In addition, the mobile application will
also provide information on what constitutes a healthy
lifestyle and further information on how to stay healthy
before pregnancy. The mobile application is available on
iOS and Android operating systems. Figure 3 presents
several screen shots from the mobile application.
Control arm
Subjects in the control arm will receive standard of care,
which is no contact with a CHP and no access to the E-
health platform. They will receive one phone call from a
research officer towards the end of the intervention
period to remind them of their endpoint visit.
Outcomes
Primary endpoint
Change in waist circumference was selected as the
primary endpoint because of its validity as a superior
measurement for assessing abdominal fat content and
associated obesity health risk, as compared to a meas-
ure such as body mass index (BMI) [24–26]. In
addition, there are existing national Malaysian data
on population waist circumference, which allow for
the study results to be comparable on a national
level. In the present trial, the primary endpoint is
predicted to provide a 2-cm reduction of waist cir-
cumference in the intervention group compared to
the control group, which will reflect a reduction of
central fat distribution. The reduction of 2 cm in
waist circumference as a primary endpoint is based
on the mean from a number of studies indicating that
a decrement of waist circumference is possible with a
lifestyle changing intervention over a period of
8 months [27–31]. The variation between the two
time-points in these studies was small (standard devi-
ation (SD) of 3–5) after the intervention period, and
we therefore assume an expected within-person esti-
mate of SD = 5.
Secondary endpoints
The secondary endpoint will be as follows:
1. Change in BMI from baseline to after 8 months
2. Change in waist-to-height ratio from baseline to
after 8 months
3. Change in waist-to-hip ratio from baseline to after
8 months
4. Change in weight from baseline to after 8 months
Table 1 Overview of the objective of each face-to-face and
phone call contact point
Contact point Objective
Contact point 1
(face-to-face)
Assessment of woman and spouse’s health risk
and behaviour: conversation starter
Introduce to use of mobile application
Initiate review of assessments and behaviour
change process
Goal setting
Contact point 2
(face-to-face)
Follow-up on use of mobile application
Provide health information as required
Review and address extrinsic supportive
and inhibiting factors
Introduce proactive coping
Contact point 3
(phone)
Follow-up on use of mobile application
Follow-up on progress based on initial goal
setting
Provide support and advice
Provide health information as required
Revise goal setting and set new goals as
relevant
Contact point 4
(phone)
Follow-up on use of mobile application
Follow-up on progress based on previously
set goals
Provide support and advice
Provide health information as required
Revise goal setting and set new goals as relevant
Contact point 5
(face-to-face)
Follow-up on use of mobile application
Follow-up on progress based on previously set goals
Provide support and advice
Provide health information as required
Revise goal setting and set new goals as
relevant
Contact point 6
(phone)
Follow-up on progress based on previously set
goals
Provide support and advice
Provide health information as required
Goal setting and planning for the future
End of intervention process
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Fig. 3 Screen shots of mobile application. a The main screen, showing the couple’s process for the particular month. The icons on top illustrate
the categories of the different challenges selected (two physical activity challenges and one healthy eating challenge). In the middle, is the
progress bar, showing the progress of the user and her spouse for this particular month. Lowest, are the selected challenges listed and how many
times they should be performed in one week. b By tapping on the challenges, a description of the different challenge is showing (example of
the healthy eating challenge). c When the challenge has been performed, the subject will ‘check-in’, and by doing that be awarded 2 points for
performing the challenges. d A timer can be set for each challenge, so a reminder will be send to the subject on the given time to perform the
challenge. e The subject is selecting the challenge out of a list set challenges. f The Flash challenge is a bonus challenge, which the subject can
select when it becomes available. This occurs randomly during the intervention period. The Flash challenge will give extra points
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5. Change in glycated haemoglobin A1c (HbA1c) from
baseline to after 8 months
6. Change in the fasting lipid profile (total cholesterol,
low-density lipoprotein cholesterol, high-density
lipoprotein cholesterol and triglycerides) from base-
line to after 8 months
7. Change in blood pressure (systolic and diastolic
blood pressure) from baseline to after 8 months
8. Change in the level of health literacy, as measured
by the European Health Literacy Survey
Questionnaire (HLC-EU-Q47) from baseline to after
8 months
9. Change in dietary intake, as measured by a Food
Frequency Questionnaire (FFQ), from baseline to
after 8 months
10.Change in physical activity and sedentary behaviour,
as measured by the International Physical Activity
Questionnaire (IPAQ) used in national health
surveys in Malaysia, from baseline to after 8 months
11.Change in stress levels, as measured by the
Depression Anxiety and Stress Scale 21-items
(DASS-21) used by general practitioners in the
Malaysian primary health care system from baseline
to after 8 months
Other endpoints
The incidence of GDM, confirmed by an oral glucose
tolerance test (OGTT), will be assessed in the subjects
who will complete the intervention period and who
become pregnant in the post-trial monitoring period.
The OGTT will be taken at weeks 26–28 of the pregnancy.
Data will be captured retrospectively and obtained from
medical charts.
Supportive data
Anthropometric measurements, blood pressure and data
on physical activity, dietary, stress and health literacy will
be collected from the subject’s spouse. Socio-demographic
data and family medical history will be collected from
both the subject and the spouse. These variables are
collected to adjust for confounding effects.
Sample size calculation
The sample size calculation is based on a 2-cm reduc-
tion in waist circumference, in the primary endpoint of
waist circumference between the intervention and control
arms at 8 months. Assuming a 5 % level of significance
(alpha = 0.05), a statistical power of 90 % (beta = 0.10) and
a SD of 5 cm using a two-sided t test, 132 women per arm
are required. Taking into consideration a 20 % drop-out
rate, and that 20 % will be pregnant, a total of 660 women
would be randomised/enrolled to ensure 264 subjects to
cover both the intervention and control arms.
Randomisation
At the baseline measurement visit, subjects will be
randomised into the intervention and control arms at
a 1:1 allocation ratio. Random allocation sequences
will be computer- generated with block sizes of six
subjects. Each clinic will be provided with a sufficient
number of identification (ID) numbers with random-
isation codes. When a subject is enrolled in the trial,
the study nurse should assign the lowest available ID
number to the subject from the list of ID numbers.
The Institute for Health System Research (IHSR)
under the MoH has prepared the randomisation list
and these are distributed to the five designated primary
health clinics in Seremban. A copy is maintained by the
IHSR.
Data collection, management and analysis
Study conduct
Study nurses will be trained to conduct the data collec-
tion at the five designated primary health clinics in
Seremban district. At the baseline assessment, the prin-
ciples of the trial will be explained again for the subject
and spouse and they will be asked to provide consent by
signing the consent form. One original copy of each
form will be kept by the study nurse who will file the
document on site. One copy of each form will be given
to the subjects. The women and their spouses will have
linked ID numbers by assigning each subject and spouse
the same ID number with subject ID ending with the
number ‘2’ and spouse ID ending with the number ‘1’
respectively.
Data collection
At baseline the subjects will undergo measurements
of waist circumference, hip circumference, weight,
height and blood pressure by following standardised
procedures based on World Health Organisation
(WHO) STEPS surveillance [32]. Only the subject in
the couple will provide a 10-mL blood sample to
measure glycated haemoglobin A1c (HbA1c) and a
fasting lipid profile (triglycerides (TG), low-density
lipoprotein cholesterol (LDL-C), high-density lipopro-
tein cholesterol (HDL-C) and total cholesterol (TC)).
Due to the need for a fasting lipid profile analysis, the
subject will be asked to come to the clinic after fasting for
a minimum of 9 h. In line with this, the data collection
time-points are planned to be in the morning. The Euro-
pean Health Literacy Tool Q-47 (HL-EU-Q47) [33] (HL-
EU Consortium 2012), the Malaysian Food Frequency
Questionnaire (FFQ), modified to be used in the current
trial [2]; the International Physical Activity Questionnaire
(IPAQ) [2]; and the Depression Anxiety Stress Scale 21-
items (DASS-21) [34, 35] will be used to collect data on
level of health literacy, dietary pattern, physical activity
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level, and stress level, respectively. Data such as socio-
demographic parameters and family history of diabetes
will be collected by structured interviews with the study
nurse. The spouse will undergo the same data measure-
ments, with the exception of blood sampling. At the end
of the data collection, and before subject and spouse leave,
data will be checked by the study nurse and site coordin-
ator or research officer, to ensure that all data forms and
questionnaires have been filled correctly. When data col-
lection is completed the data collection forms and ques-
tionnaires will be signed-off by the study nurse and site
coordinator or research officer. At the end of the baseline
visit, if the subject is randomised to the intervention, the
first contact with a CHP will be made. The subject and
spouse will be introduced to the mobile application and it
will be installed on the subject’s and spouse’s smartphone
device. If the subject and spouse have sufficient time the
CHP will proceed with the first contact point. If the sub-
ject and spouse do not have the time, an appointment will
be set in the next 5 days either at the clinic or at the cou-
ple’s house. The same measurements, except height,
socio-demographic parameters and medical history, de-
scribed above will be conducted at the endpoint visit
(Table 2).
If a subject becomes pregnant within the 8-month
intervention period, she will be withdrawn from the trial.
Exit measurements, which are similar to those at the
endpoint visit, will be performed only for subjects who
become pregnant between 4.1 and 8 months from base-
line. For those who become pregnant between baseline
and month 4 in the intervention period, no measurements
will be taken.
Data management
All data will be managed and stored with protection of
data privacy. Documentation as well as corrections, if
necessary, will be done in accordance to Good Clinical
Practice guidelines. All protocol-required information
collected during the trial must be entered on a data col-
lection form containing the four questionnaires. The ori-
ginal completed data collection form will be send to
IHSR, MoH Malaysia, where double data entry will be
performed by two independent data clerks. The com-
pleteness, validity and plausibility of data are examined by
validating programmes, which thereby generate queries.
The generated queries will be checked with original data
collection forms and all changes from the original data are
documented on audit files. Data will be maintained and
Table 2 Data collection at each time-point in the Jom Mama trial
Data collection on woman;● Data collection on spouse; aFFQ Food Frequency Questionnaire, bIPAQ International Physical Activity Questionnaire, cDASS-21
Depression Anxiety and Stress Scale 21-items, d Fasting lipid profile: will be measured as a combination of: total cholesterol (TC) level, low-density lipoprotein
cholesterol (LDL-C) level, high-density lipoprotein cholesterol (HDL-C) level and triglyceride (TG) level; 5Exit point visit will occur if the woman becomes
pregnant between 4.1 months and 8 months after randomisation
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analysed in the statistical Stata programme, version 12.0
or higher (StataCorp LP). Monitoring will be performed
regularly by an independent clinical research organisation
from Malaysia to check the completeness of the contents
of records and the data collection forms, the adherence to
the protocol and the progress of enrolment.
Statistical analysis
The null hypothesis is that there is no difference in the
change in waist circumference between the intervention
and the control group after the 8-month intervention. The
alternative hypothesis is that the decrement in waist cir-
cumference will be bigger in the intervention group com-
pared to the control group after the 8-month intervention.
A linear regression model will be used to assess the differ-
ence in the change of waist circumference from baseline
to end of intervention, with the difference in waist circum-
ference as the independent variable, treatment (interven-
tion versus control) and baseline waist circumference as
covariates. Additional tests will be performed for the im-
pact of the intervention in both high- (waist circumfer-
ence above 80 cm) and low-risk (waist circumference
below 80 cm) groups. This will be done by subgroup ana-
lysis or by assessing the proportional changes in the pri-
mary endpoint. Each subgroup will also be analysed in a
linear regression model. The continuous secondary end-
points will be analysed in a linear regression model,
whereas the difference in the change of each secondary
endpoint from baseline to end of intervention, will be the
dependent variable, treatment (intervention versus con-
trol) and baseline value as covariate. Regarding health lit-
eracy (HL-EU-Q47), physical activity (IPAQ) and stress
(DASS-21) all the variables are ordinal and, therefore, in-
dependence between intervention and control groups will
be tested with the chi-squared test. Change in nutrient
intakes will be compared between the groups using a gen-
eralised linear model, with additional adjustments for total
energy intake. Nutrient and food patterns before and after
the intervention will be explored in both groups separately
by using dimension reduction techniques such as principal
component analysis. Multivariate analysis will be per-
formed to assess the association between exposure to the
intervention, primary endpoints and secondary endpoints
(BMI, waist-to-height and waist-to-hip ratio, HbA1c, lipid
profile, blood pressure, health literacy, physical activity,
dietary intake and stress level) using linear regressions. In
this model the secondary endpoint will be included in the
model as covariates and the estimated coefficients will be
presented unadjusted and adjusted for appropriate and/or
effect modifier and/or confounders. Furthermore, interac-
tions between the secondary endpoints will also be ex-
plored. Several supportive analyses will be performed. The
first supportive analysis will explore the relation between
subjects’ and spouses’ change in waist circumference and
other anthropometric measurements, diet, physical activ-
ity, health literacy and stress. A second supportive analysis
will explore whether a short intervention period (subjects
who become pregnant between 4.1 and 8 months in the
intervention period), will also have an impact on the pri-
mary endpoint and secondary endpoints. A time variable
explaining how long they have been included in the inter-
vention will be included in the models as a covariate. At
the end of the 12-month post-intervention monitoring
period, a full analysis will be conducted on subjects who
become pregnant within 12 months after completing the
intervention. This will be done by assessing the incidences
of GDM among women who became pregnant between
treatment groups, using a chi-squared test. Additionally, a
logistic regression model to explore associations between
the number of subjects with GDM and several secondary
endpoints will be conducted.
Ethical, regulatory and data management considerations
The study protocol version 4.0 dated 12 August 2015 has
received ethical and governance approvals by the Medical
Research and Ethics Committee of the Ministry of Health
Malaysia (protocol number: NMRR-14-904-21963) on 21
September 2015. The study is performed in compliance
with the Declaration of Helsinki. Written informed consent
will be taken from each participant prior to study enrolment
by trained study nurse. The trial was registered at Clinical-
Trials.gov, Identifier: NCT02617693 on 30 November 2015.
Safety monitoring
In the event of an abnormal laboratory test results for
Hb1Ac or a newly suspected or diagnosed health con-
cern during a subject’s measurements (i.e. high blood
pressure or a high score in the DASS-21 tool) at baseline/
exit point/endpoint, the subject will be referred to their
primary health care physician for further examination.
Discussion
This study protocol describes the first community-based
RCT to examine the efficacy of a complex behavioural
change lifestyle intervention in improving the pre-
pregnancy health of young Malaysian couples. Other
studies assessing the prevention of GDM and T2DM
have mainly focused on high-risk groups or the interven-
tion entry point has been in the first trimester of the
women’s pregnancy [36–40], whereas few RCT studies
exist on low-risk populations or on an intervention entry
point in the pre-conception period [41]. To develop
population strategies, instead of targeting high-risk groups
it is imperative to widen the focus to the general popula-
tion, especially in a country such as Malaysia where the
prevalence of diabetes and obesity has increased alarmingly
in the last 10 years [2]. One European study has shown
that limited guidelines and policies exist in this area, as
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guidelines and policies are designed to mainly target
high-risk groups [42]. Therefore, this study may con-
tribute evidence to this important area which is
needed to support policy-makers in making rational
decisions to improve population health.
A pilot test was conducted prior to trial implementa-
tion and has identified a number of challenges. A major
challenge that has been found is that the intervention
addresses a challenging period for young Malaysian cou-
ples, whereby busy work schedules and lack of time
affect participation rates and generate low interest in
such an intervention. While it would be ideal to collect
spousal data at baseline and endpoint, it will be made
optional for the spouse to attend both baseline and end-
point visits if they are unable to attend in order to con-
tinue with recruitment. Based on these observations, it
is expected that the recruitment period will be longer
than initially anticipated.
The combination of motivational interviewing
through a CHP and E-health platform is a novel ap-
proach. Training the community nurses to become CHPs
involves an interactive approach beyond their conven-
tional training programmes; this provided new learning
experiences for these nurses to build higher capacity in
patient engagement. The E-health platform is also a new
experience for the primary health care services in the
Seremban district and considerable time was needed to
train community nurses with the necessary IT skills. An-
other key challenge faced was the limited usage of the E-
health mobile application due to poor Internet connectiv-
ity in the district of Seremban. In mitigating this challenge,
Wi-Fi hotspots in the designated primary health clinics
have been set up to enable participating women and their
spouses to download the mobile application in a secured
Internet environment. Additionally, several changes have
been made to the E-health platform to make it more
robust.
The proposed trial will not directly assess the long-term
effects of the intervention on the risk of the offspring de-
veloping T2DM. Given the complexity of developing,
implementing and evaluating complex behavioural change
lifestyle interventions, this trial will focus on improving
the pre-conception health in young women prior to their
first pregnancy.
Trial status
The trial started recruitment in November 2015. The
trial is expected to be completed by July 2017.
Additional file
Additional file 1: The SPIRIT recommendations for clinical trials protocols.
(DOC 117 kb)
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